Rock-Springs-Capital-Management-Lp

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
96
Total Value
1747790415
Accession Number
0001172661-25-001953
Form Type
13F-HR
Manager Name
Rock-Springs-Capital-Management-Lp
Data Enrichment
94% identified
90 identified6 unidentified

Holdings

96 positions • $1.7B total value
Manager:
Search and click to pin securities to the top
Janux Therapeutics, Inc.
Shares:204.5K
Value:$5.5M
% of Portfolio:0.3% ($5.5M/$1.7B)
Dyne Therapeutics, Inc.
Shares:524.5K
Value:$5.5M
% of Portfolio:0.3% ($5.5M/$1.7B)
38341PAA0
Shares:
Value:$5.3M
% of Portfolio:0.3% ($5.3M/$1.7B)
Mineralys Therapeutics, Inc.
Shares:320.8K
Value:$5.1M
% of Portfolio:0.3% ($5.1M/$1.7B)
Cullinan Therapeutics, Inc.
Shares:644.6K
Value:$4.9M
% of Portfolio:0.3% ($4.9M/$1.7B)
64157F103
Shares:800.5K
Value:$4.7M
% of Portfolio:0.3% ($4.7M/$1.7B)
Bicara Therapeutics Inc.
Shares:336.1K
Value:$4.4M
% of Portfolio:0.3% ($4.4M/$1.7B)
NOVAVAX INC
Shares:650.0K
Value:$4.2M
% of Portfolio:0.2% ($4.2M/$1.7B)
G52441105
Shares:145.0K
Value:$3.6M
% of Portfolio:0.2% ($3.6M/$1.7B)
Gossamer Bio, Inc.
Shares:3.3M
Value:$3.6M
% of Portfolio:0.2% ($3.6M/$1.7B)
Pulmonx Corp
Shares:503.7K
Value:$3.4M
% of Portfolio:0.2% ($3.4M/$1.7B)
Inozyme Pharma, Inc.
Shares:3.4M
Value:$3.1M
% of Portfolio:0.2% ($3.1M/$1.7B)
Beam Therapeutics Inc.
Shares:150.0K
Value:$2.9M
% of Portfolio:0.2% ($2.9M/$1.7B)
Alphatec Holdings, Inc.
Shares:267.5K
Value:$2.7M
% of Portfolio:0.2% ($2.7M/$1.7B)
Sagimet Biosciences Inc.
Shares:787.8K
Value:$2.6M
% of Portfolio:0.1% ($2.6M/$1.7B)
EDAP TMS SA
Shares:1.3M
Value:$2.5M
% of Portfolio:0.1% ($2.5M/$1.7B)
Jasper Therapeutics, Inc.
Shares:545.2K
Value:$2.3M
% of Portfolio:0.1% ($2.3M/$1.7B)
LENZ Therapeutics, Inc.
Shares:83.1K
Value:$2.1M
% of Portfolio:0.1% ($2.1M/$1.7B)
REGENERON PHARMACEUTICALS, INC.
Shares:2.8K
Value:$1.8M
% of Portfolio:0.1% ($1.8M/$1.7B)
Apellis Pharmaceuticals, Inc.
Shares:80.0K
Value:$1.7M
% of Portfolio:0.1% ($1.7M/$1.7B)